The San Diego Heart Research Institute and the Department of Biology, San Diego State University, San Diego, CA.
Department of Pharmacology, UC Davis, Davis, CA.
J Am Heart Assoc. 2017 Oct 10;6(10):e006837. doi: 10.1161/JAHA.117.006837.
Aberrant Ca handling is a prominent feature of heart failure. Elucidation of the molecular mechanisms responsible for aberrant Ca handling is essential for the development of strategies to blunt pathological changes in calcium dynamics. The peptidyl-prolyl - isomerase peptidyl-prolyl isomerase 1 (Pin1) is a critical mediator of myocardial hypertrophy development and cardiac progenitor cell cycle. However, the influence of Pin1 on calcium cycling regulation has not been explored. On the basis of these findings, the aim of this study is to define Pin1 as a novel modulator of Ca handling, with implications for improving myocardial contractility and potential for ameliorating development of heart failure.
Pin1 gene deletion or pharmacological inhibition delays cytosolic Ca decay in isolated cardiomyocytes. Paradoxically, reduced Pin1 activity correlates with increased sarco(endo)plasmic reticulum calcium ATPase (SERCA2a) and Na/Ca exchanger 1 protein levels. However, SERCA2a ATPase activity and calcium reuptake were reduced in sarcoplasmic reticulum membranes isolated from Pin1-deficient hearts, suggesting that Pin1 influences SERCA2a function. SERCA2a and Na/Ca exchanger 1 associated with Pin1, as revealed by proximity ligation assay in myocardial tissue sections, indicating that regulation of Ca handling within cardiomyocytes is likely influenced through Pin1 interaction with SERCA2a and Na/Ca exchanger 1 proteins.
Pin1 serves as a modulator of SERCA2a and Na/Ca exchanger 1 Ca handling proteins, with loss of function resulting in impaired cardiomyocyte relaxation, setting the stage for subsequent investigations to assess Pin1 dysregulation and modulation in the progression of heart failure.
钙处理异常是心力衰竭的一个显著特征。阐明导致钙处理异常的分子机制对于开发减轻钙动力学病理变化的策略至关重要。肽基脯氨酰顺反异构酶肽基脯氨酰异构酶 1(Pin1)是心肌肥厚发展和心脏祖细胞周期的关键介质。然而,Pin1 对钙循环调节的影响尚未得到探索。基于这些发现,本研究旨在将 Pin1 定义为钙处理的新型调节剂,这对改善心肌收缩力和改善心力衰竭的发展具有重要意义。
Pin1 基因缺失或药理学抑制可延迟分离的心肌细胞中胞质 Ca 衰减。矛盾的是,减少 Pin1 活性与肌浆网(内)质网钙 ATP 酶(SERCA2a)和钠/钙交换器 1 蛋白水平增加相关。然而,从 Pin1 缺陷心脏中分离的肌浆网膜中的 SERCA2a 三磷酸腺苷酶(ATPase)活性和钙摄取减少,表明 Pin1 影响 SERCA2a 功能。SERCA2a 和钠/钙交换器 1 与 Pin1 相关,如心肌组织切片中的邻近连接测定所揭示的,表明肌细胞内钙处理的调节可能通过 Pin1 与 SERCA2a 和钠/钙交换器 1 蛋白的相互作用来影响。
Pin1 是 SERCA2a 和钠/钙交换器 1 Ca 处理蛋白的调节剂,功能丧失导致心肌细胞松弛受损,为随后评估 Pin1 失调和在心力衰竭进展中的调节的研究奠定了基础。